Logo do repositório

EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome

dc.contributor.authorDa Costa, Bruno Henrique Bressan
dc.contributor.authorBecker, Aline Paixao
dc.contributor.authorNeder, Luciano
dc.contributor.authorGoncalves, Paola Gyuliane [UNESP]
dc.contributor.authorDe Oliveira, Cristiane [UNESP]
dc.contributor.authorPolverini, Allan Dias
dc.contributor.authorClara, Carlos Afonso
dc.contributor.authorTeixeira, Gustavo Ramos
dc.contributor.authorReis, Rui Manuel
dc.contributor.authorBidinotto, Lucas Tadeu [UNESP]
dc.contributor.institutionBarretos Cancer Hospital
dc.contributor.institutionDr. Paulo Prata - FACISB
dc.contributor.institutionOhio State University
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionUniversity of Minho
dc.contributor.institutionICVS/3B's - PT Government Associate Laboratory
dc.date.accessioned2023-03-01T21:10:46Z
dc.date.available2023-03-01T21:10:46Z
dc.date.issued2022-07-01
dc.description.abstractBackground: Despite the advances in glioblastoma (GBM) treatment, the average life span of patients is 14 months. Therefore, it is urgent to identity biomarkers of prognosis, treatment response, or development of novel treatment strategies. We previously described the association of high epidermal growth factor-like domain multiple 7 (EGFL7) expression and unfavorable outcome of pilocytic astrocytoma patients. The present study aims to analyze the prognostic potential of EGFL7 in GBM isocitrate dehydrogenase (IDH)-wildtype, using immunohistochemistry and in silico approaches. Methods: Spearman's correlation analysis of The Cancer Genome Atlas RNA sequencing data was performed. The genes strongly correlated to EGFL7 expression were submitted to enrichment gene ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. Additionally, EGFL7 expression was associated with patient overall survival. The expression of EGFL7 was analyzed through immunohistochemistry in 74 GBM IDH-wildtype patients' samples, and was associated with clinicopathological data and overall survival. Results: In silico analysis found 78 genes strongly correlated to EGFL7 expression. These genes were enriched in 40 biological processes and eight KEGG pathways, including angiogenesis/vasculogenesis, cell adhesion, and phosphoinositide 3-kinase-Akt, Notch, and Rap1 signaling pathways. The immunostaining showed high EGFL7 expression in 39 cases (52.7%). High immunolabelling was significantly associated with low Karnofsky Performance Status and poor overall survival. Cox analysis showed that GBMs IDH-wildtype with high EGFL7 expression presented a higher risk of death compared to low expression (hazard ratio, 1.645; 95% confidence interval, 1.021 to 2.650; p = .041). Conclusions: This study gives insights regarding the genes that are correlated with EGFL7, as well as biological processes and signaling pathways, which should be further investigated in order to elucidate their role in glioblastoma biology.en
dc.description.affiliationMolecular Oncology Research Center Barretos Cancer Hospital, Barretos
dc.description.affiliationBarretos School of Health Sciences Dr. Paulo Prata - FACISB, Barretos
dc.description.affiliationOhio State University Department of Radiation Oncology
dc.description.affiliationDepartment of Pathology School of Medicine of Ribeirao Preto University of Sao Paulo, Ribeirao Preto
dc.description.affiliationUNESP - Univ. Estadual Paulista School of Medicine Department of Pathology, Botucatu
dc.description.affiliationDepartment of Neurosurgery Barretos Cancer Hospital, Barretos
dc.description.affiliationDepartment of Pathology Barretos Cancer Hospital, Barretos
dc.description.affiliationLife and Health Sciences Research Institute (ICVS) School of Medicine University of Minho
dc.description.affiliationICVS/3B's - PT Government Associate Laboratory, Guimaraes
dc.description.affiliationUnespUNESP - Univ. Estadual Paulista School of Medicine Department of Pathology, Botucatu
dc.format.extent205-211
dc.identifierhttp://dx.doi.org/10.4132/jptm.2022.04.22
dc.identifier.citationJournal of Pathology and Translational Medicine, v. 56, n. 4, p. 205-211, 2022.
dc.identifier.doi10.4132/jptm.2022.04.22
dc.identifier.issn2383-7845
dc.identifier.issn2383-7837
dc.identifier.scopus2-s2.0-85136908523
dc.identifier.urihttp://hdl.handle.net/11449/241570
dc.language.isoeng
dc.relation.ispartofJournal of Pathology and Translational Medicine
dc.sourceScopus
dc.subjectEGFL7
dc.subjectGlioblastoma IDH-wildtype
dc.subjectNotch pathway
dc.subjectPI3K-Akt pathway
dc.subjectRap1 pathway
dc.titleEGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcomeen
dc.typeArtigopt
dspace.entity.typePublication
relation.isDepartmentOfPublicationa245add5-d5dd-4133-b280-ff763c412c47
relation.isDepartmentOfPublication.latestForDiscoverya245add5-d5dd-4133-b280-ff763c412c47
relation.isOrgUnitOfPublicationa3cdb24b-db92-40d9-b3af-2eacecf9f2ba
relation.isOrgUnitOfPublication.latestForDiscoverya3cdb24b-db92-40d9-b3af-2eacecf9f2ba
unesp.author.orcid0000-0003-4044-9745 0000-0003-4044-9745[1]
unesp.author.orcid0000-0002-8695-810X[2]
unesp.author.orcid0000-0003-3790-3476 0000-0003-3790-3476[3]
unesp.author.orcid0000-0001-6515-3102 0000-0001-6515-3102[4]
unesp.author.orcid0000-0002-3729-6904 0000-0002-3729-6904[5]
unesp.author.orcid0000-0001-6363-6290[6]
unesp.author.orcid0000-0002-9908-507X[7]
unesp.author.orcid0000-0001-8363-3513 0000-0001-8363-3513[8]
unesp.author.orcid0000-0002-9639-7940 0000-0002-9639-7940 0000-0002-9639-7940[9]
unesp.author.orcid0000-0002-6909-8347 0000-0002-6909-8347 0000-0002-6909-8347[10]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.departmentPatologia - FMBpt

Arquivos